Export 3 results:
Author [ Title(Desc)] Type Year
Filters: Author is Chamberlain, James M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
J. M. Chamberlain, Okada, P., Holsti, M., Mahajan, P., Brown, K. M., Vance, C., Gonzalez, V., Lichenstein, R., Stanley, R., Brousseau, D. C., Grubenhoff, J., Zemek, R., Johnson, D. W., Clemons, T. E., and Baren, J., “Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial.”, JAMA, vol. 311, no. 16, pp. 1652-60, 2014.
P
L. C. Ku, Hornik, C. P., Beechinor, R. J., Chamberlain, J. M., Guptill, J. T., Harper, B., Capparelli, E. V., Martz, K., Anand, R., Cohen-Wolkowiez, M., and Gonzalez, D., “Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status Epilepticus.”, CPT Pharmacometrics Syst Pharmacol, vol. 7, no. 11, pp. 718-727, 2018.
V
M. Holsti, Zemek, R., Baren, J., Stanley, R. M., Mahajan, P., Vance, C., Brown, K. M., Gonzalez, V., King, D., Jacobsen, K., Shreve, K., van de Bruinhorst, K., Jones, A. Marie, and Chamberlain, J. M., “Variation of community consultation and public disclosure for a pediatric multi-centered "Exception from Informed Consent" trial.”, Clin Trials, vol. 12, no. 1, pp. 67-76, 2015.